Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6

Cellular Signalling

Volumn 17, Issue 5, 2005, Pages 647-653

  Beazely, Michael A ^a   Watts, Val J ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

AC6; D2 dopamine receptor; EGF; Raf1; Superactivation

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE 6; DELTA OPIATE RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; PROTEIN KINASE C; PROTEIN TYROSINE KINASE INHIBITOR; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DATA ANALYSIS; EMBRYO CELL; ENZYME ACTIVATION; ENZYME STABILITY; GENE CONSTRUCT; HUMAN; HUMAN CELL; KIDNEY CELL; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR SENSITIVITY; SENSITIZATION; SIGNAL TRANSDUCTION;

CRICETINAE; CRICETULUS GRISEUS;

EID: 15944374785     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2004.10.003     Document Type: Article

References (29)

1. V.J. Watts J. Pharmacol. Exp. Ther. 302 2002 1
2. T. Avidor-Reiss, I. Nevo, R. Levy, T. Pfeuffer, and Z. Vogel J. Biol. Chem. 271 1996 21309
3. C.A. Johnston, M.A. Beazely, A.F. Vancura, J.K. Wang, and V.J. Watts J. Neurochem. 82 2002 1087
4. E.V. Varga, M.K. Rubenzik, D. Stropova, M. Sugiyama, V. Grife, V.J. Hruby, K.C. Rice, W.R. Roeske, and H.I. Yamamura J. Pharmacol. Exp. Ther. 306 2003 109
5. V.J. Watts, and K.A. Neve Mol. Pharmacol. 50 1996 966
6. E.J. Nestler, and G.K. Aghajanian Science 278 1997 58
7. E.V. Varga, D. Stropova, M. Rubenzik, M. Wang, R.S. Landsman, W.R. Roeske, and H.I. Yamamura Eur. J. Pharmacol. 348 1998 R1
8. E.V. Varga, D. Stropova, M. Rubenzik, S. Waite, W.R. Roeske, and H.I. Yamamura Eur. J. Pharmacol. 364 1999 R1
9. E.V. Varga, M. Rubenzik, V. Grife, M. Sugiyama, D. Stropova, W.R. Roeske, and H.I. Yamamura Eur. J. Pharmacol. 451 2002 101
10. C.A. Johnston, M.A. Beazely, M.L. Bilodeau, O. Andrisani, and V.J. Watts J. Neurochem. 88 2004 1497
11. Y. Chen, A. Harry, J. Li, M.J. Smit, X. Bai, R. Magnusson, J.P. Pieroni, G. Weng, and R. Iyengar Proc. Natl. Acad. Sci. U. S. A. 94 1997 14100
12. T.H. Lin, H.L. Lai, Y.Y. Kao, C.N. Sun, M.J. Hwang, and Y. Chern J. Biol. Chem. 277 2002 15721
13. A. Rodriguez-Pena, and E. Rozengurt Biochem. Biophys. Res. Commun. 120 1984 1053
14. S. Stabel, A. Rodriguez-Pena, S. Young, E. Rozengurt, and P.J. Parker J. Cell. Physiol. 130 1987 111
15. E.V. Varga, H.I. Yamamura, M.K. Rubenzik, D. Stropova, E. Navratilova, and W.R. Roeske Life Sci. 74 2003 299
16. P. Rogue, J. Zwiller, A.N. Malviya, and G. Vincendon Biochem. Int. 22 1990 575
17. N.H. Fraeyman, and K. Vermis Pharmacol. Res. 48 2003 535
18. Y.F. Liu, O. Civelli, D.K. Grandy, and P.R. Albert J. Neurochem. 59 1992 2311
19. Y. Ueda, S. Hirai, S. Osada, A. Suzuki, K. Mizuno, and S. Ohno J. Biol. Chem. 271 1996 23512
20. S.K. Sharma, W.A. Klee, and M. Nirenberg Proc. Natl. Acad. Sci. U. S. A. 72 1975 3092
21. T. Avidor-Reiss, I. Nevo, D. Saya, M. Bayewitch, and Z. Vogel J. Biol. Chem. 272 1997 5040
22. I. Nevo, T. Avidor-Reiss, R. Levy, M. Bayewitch, and Z. Vogel Neuropharmacology 39 2000 364
23. M.H. Rhee, I. Nevo, T. Avidor-Reiss, R. Levy, and Z. Vogel Mol. Pharmacol. 57 2000 746
24. J.M. Thomas, and B.B. Hoffman Mol. Pharmacol. 49 1996 907
25. E.J. Nestler Nat. Rev., Neurosci. 2 2001 119
26. Y. Chern Cell. Signal. 12 2000 195
27. F.C. Liu, G.C. Wu, S.T. Hsieh, H.L. Lai, H.F. Wang, T.W. Wang, and Y. Chern FEBS Lett. 436 1998 92
28. K.D. Lustig, B.R. Conklin, P. Herzmark, R. Taussig, and H.R. Bourne J. Biol. Chem. 268 1993 13900
29. M.G. Cumbay, and V.J. Watts J. Pharmacol. Exp. Ther. 297 2001 1201